Codexis Akcija

Codexis 40. noteikums

40. noteikums no Codexis (CDXS) uz 2026. g. 18. aug. ir -40,69 %. Iepriekšējā gadā 40. noteikums bija -114,00 % — izmaiņas -64,31 % (augstāks).

40. noteikums

-40,69 %

YoY

-64,31%

Pēdējoreiz atjaunināts:

40. noteikums no Codexis ir 2026 -40,69 % . 40. noteikums no Codexis bija 2025 -114,00 % . Tas samazinās par -64,31% augstāks salīdzinājumā ar iepriekšējo gadu.
Access this data via the Eulerpool API

Codexis Akciju analīze

Ko dara Codexis? Codexis Inc. is an American biotechnology company that specializes in developing innovative biological solutions for a variety of industries. The company was founded in 2002 and is headquartered in Redwood City, California. Business Model: Codexis is service-oriented and provides customized enzyme solutions for companies looking to improve their products through sustainable processes. The company has developed a unique platform called Rational Protein Engineering, which allows for the development of specific enzymes for various industries. Customers benefit from enzyme optimization expertise and know-how. Divisions: Codexis operates in the fields of life sciences, materials science, agrochemicals, and biofuels. 1. Life Sciences: Codexis specializes in the production of enzymes and biocatalysts for the pharmaceutical industry in the life sciences division. The goal is to provide a faster and more efficient manufacturing process for pharmaceutical active ingredients. The company has successfully developed active ingredients for antibodies, lipids, uric acid, and antivirals. 2. Materials Science: In the materials science division, Codexis specializes in the production of enzymes for materials such as dyes, polymers, and cosmetic products. Codexis ensures that these products are efficiently manufactured without the use of environmentally harmful chemicals. 3. Agrochemicals: Codexis offers customized enzyme solutions to agrochemical manufacturers that reduce the use of chemicals and benefit the environment. These enzymes help in the production of pesticides and other agrochemicals. 4. Biofuels: In the biofuels division, Codexis specializes in the production of enzymes for processing corn, harvested plants, or waste products. These enzymes help enable cost-effective biofuel production. Products: Codexis has developed a wide range of products tailored to the needs of various industries. Some of the products recently introduced to the market by Codexis include: 1. CodeEvolver: CodeEvolver is a platform that allows biotechnology companies to quickly create customized enzyme solutions for their specific needs. The process is fully automated and results in a significant reduction in development time and costs. 2. Codex® screening panels: Codexis offers various screening panels that allow customers to quickly and efficiently select the enzymes best suited for their purposes. The panels are suitable for industries including pharmaceuticals, chemicals, and plant protection. 3. Codex® enzymes: Codexis offers a wide range of enzymes specifically designed for different industry needs. This includes enzymes for the production of biofuels, pesticides, cosmetic products, and pharmaceuticals. Overall, Codexis Inc. has demonstrated its ability to deepen the understanding of biocatalysts and introduce innovative biological processes in a variety of industries through its unique Rational Protein Engineering platform. Codexis ir viens no populārākajiem uzņēmumiem Eulerpool.

Bieži uzdotie jautājumi par Codexis akciju

Codexis 40. noteikums 2026. gadā ir -40,69 %.

Vietnē Eulerpool varat atrast pilnīgu 40. noteikums Codexis vēsturisko attīstību kopš 2006. gada — ar gada vērtībām, grafikiem un detalizētu analīzi.

40 noteikums paredz, ka uzņēmuma ieņēmumu izaugsmes temps plus peļņas marža jāpārsniedz 40%. Tas tiek plaši izmantots SaaS un augstas izaugsmes uzņēmumu novērtēšanai.

Access this data via the Eulerpool API

Kvalitāte — Codexis

Visas kategorijas